Actinic Keratoses (AK) are common precancerous skin lesions that develop as a result of long-term sun exposure. If left untreated 5-10% can progress to squamous or basal cell carcinomas that can be life threatening. Melbourne Pharma is passionate about preventative therapy. We encourage everyone over 40 to have an annual full-body Dermatology exam and treat any concerning lesions.
At Melbourne Pharma, we offer various combinations of the most popular AK field therapy agents to help your Dermatologist clear and manage unwanted pre-cancerous lesions.
Compounded AK/Neoplasia Options
5-Fluorouracil in multiple strengths
5-Fluorouracil/Calcipotriene, in full and half-strength.
Imiquimod-in our convenient pump container, no messy packets and waste.
Imiquimod/Calcipotriene (new study).
Benefits of Compounded AK/Neoplasia Solutions
Access to the latest therapies based on published studies.
Convenient, easy to use packaging.
Affordable pricing, even for patients with large coverage areas.